Probing the interaction of Arg9Cys mutated phospholamban with phospholipid bilayers by solid-state NMR spectroscopy

Biochimica et Biophysica Acta - Biomembranes

Volumn 1828, Issue 11, 2013, Pages 2444-2449

  Yu, Xueting ^a   Lorigan, Gary A ^a  

^a MIAMI UNIVERSITY   (United States)

Author keywords

Membrane interaction; Multilamellar vesicle; NMR spectroscopy; Phospholamban; Solid state

Indexed keywords

ARGININE; CYSTEINE; PHOSPHOLAMBAN;

ARTICLE; CONTROLLED STUDY; HYDROPHOBICITY; LAMELLAR BODY; LOSS OF FUNCTION MUTATION; MULTILAMELLAR VESICLE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN STRUCTURE; SURFACE PROPERTY; WILD TYPE;

MEMBRANE INTERACTION; MULTILAMELLAR VESICLE; PHOSPHOLAMBAN; SOLID-STATE NMR SPECTROSCOPY;

ARGININE; CALCIUM-BINDING PROTEINS; CYSTEINE; LIPID BILAYERS; MOLECULAR PROBES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHOSPHOLIPIDS;

EID: 84882646469     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2013.07.003     Document Type: Article

References (61)

1. D.H. MacLennan, and E.G. Kranias Phospholamban: a crucial regulator of cardiac contractility Nat. Rev. Mol. Cell Biol. 4 2003 566 577
2. B. Mueller, C.B. Karim, I.V. Negrashov, H. Kutchai, and D.D. Thomas Direct detection of phospholamban and sarcoplasmic reticulum Ca-ATPase interaction in membranes using fluorescence resonance energy transfers Biochemistry 43 2004 8754 8765
3. C. Toyoshima, M. Asahi, Y. Sugita, R. Khanna, T. Tsuda, and D.H. MacLennan Modeling of the inhibitory interaction of phospholamban with the Ca2 + ATPase Proc. Natl. Acad. Sci. U. S. A. 100 2003 467 472
4. Z. Chen, B.L. Akin, and L.R. Jones Ca(2 +) binding to site I of the cardiac Ca(2 +) pump is sufficient to dissociate phospholamban J. Biol. Chem. 285 2010 3253 3260
5. D. Catalucci, M.V.G. Latronico, M. Ceci, F. Rusconi, H.S. Young, P. Gallo, M. Santonastasi, A. Bellacosa, J.H. Brown, and G. Condorelli At increases sarcoplasmic reticulum Ca(2 +) cycling by direct phosphorylation of phospholamban at Thr(17) J. Biol. Chem. 284 2009 28180 28187
6. N.J. Traaseth, L. Shi, R. Verardi, D.G. Mullen, G. Barany, and G. Veglia Structure and topology of monomeric phospholamban in lipid membranes determined by a hybrid solution and solid-state NMR approach Proc. Natl. Acad. Sci. U. S. A. 106 2009 10165 10170
7. R. Verardi, L. Shi, N.J. Traaseth, N. Walsh, and G. Veglia Structural topology of phospholamban pentamer in lipid bilayers by a hybrid solution and solid-state NMR method Proc. Natl. Acad. Sci. U. S. A. 108 2011 9101 9106
8. O.C. Andronesi, S. Becker, K. Seidel, H. Heise, H.S. Young, and M. Baldus Determination of membrane protein structure and dynamics by magic-angle-spinning solid-state NMR spectroscopy J. Am. Chem. Soc. 127 2005 12965 12974
9. K. Oxenoid, and J.J. Chou The structure of phospholamban pentamer reveals a channel-like architecture in membranes Proc. Natl. Acad. Sci. U. S. A. 102 2005 10870 10875
10. N.J. Traaseth, and G. Veglia Probing excited states and activation energy for the integral membrane protein phospholamban by NMR CPMG relaxation dispersion experiments Biochim. Biophys. Acta 1798 2010 77 81
11. P. Lian, D.-Q. Wei, J.-F. Wang, and K.-C. Chou An allosteric mechanism inferred from molecular dynamics simulations on phospholamban pentamer in lipid membranes PLoS One 6 2011
12. K. Seidel, O.C. Andronesi, J. Krebs, C. Griesinger, H.S. Young, S. Becker, and M. Baldus Structural characterization of Ca2 +-ATPase-bound phospholarnban in lipid bilayers by solid-state nuclear magnetic resonance (NMR) spectroscopy Biochemistry 47 2008 4369 4376
13. L.R. Masterson, T. Yu, L. Shi, Y. Wang, M. Gustavsson, M.M. Mueller, and G. Veglia cAMP-dependent protein kinase A selects the excited state of the membrane substrate phospholamban J. Mol. Biol. 412 2011 155 164
14. M.G. Paterlini, and D.D. Thomas The alpha-helical propensity of the cytoplasmic domain of phospholamban: a molecular dynamics simulation of the effect of phosphorylation and mutation Biophys. J. 88 2005 3243 3251
15. M. Sayadi, and M. Feig Role of conformational sampling of Ser16 and Thr17-phosphorylated phospholamban in interactions with SERCA Biochim. Biophys. Acta Biomembr. 1828 2013 577 585
16. H. Ghimire, S. Abu-Baker, I.D. Sahu, A.D. Zhou, D.J. Mayo, R.T. Lee, and G.A. Lorigan Probing the helical tilt and dynamic properties of membrane-bound phospholamban in magnetically aligned bicelles using electron paramagnetic resonance spectroscopy Biochim. Biophys. Acta Biomembr. 1818 2012 645 650
17. C.B. Karim, Z.W. Zhang, E.C. Howard, K.D. Torgersen, and D.D. Thomas Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA J. Mol. Biol. 358 2006 1032 1040
18. S. Abu-Baker, J.-X. Lu, S. Chu, K.K. Shetty, P.L. Gor'kov, and G.A. Lorigan The structural topology of wild-type phospholamban in oriented lipid bilayers using N-15 solid-state NMR spectroscopy Prot. Sci. 16 2007 2345 2349
19. G.X. Chu, L. Li, Y. Sato, J.M. Harrer, V.J. Kadambi, B.D. Hoit, D.M. Bers, and E.G. Kranias Pentameric assembly of phospholamban facilitates inhibition of cardiac function in vivo J. Biol. Chem. 273 1998 33674 33680
20. J.P. Schmitt, M. Kamisago, M. Asahi, G.H. Li, F. Ahmad, U. Mende, E.G. Kranias, D.H. MacLennan, J.G. Seidman, and C.E. Seidman Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban Science 299 2003 1410 1413
21. K.N. Ha, L.R. Masterson, Z. Hou, R. Verardi, N. Walsh, G. Veglia, and S.L. Robia Lethal Arg9Cys phospholamban mutation hinders Ca(2 +)-ATPase regulation and phosphorylation by protein kinase A Proc. Natl. Acad. Sci. U. S. A. 108 2011 2735 2740
22. D.K. Ceholski, C.A. Trieber, C.F.B. Holmes, and H.S. Young Lethal, hereditary mutants of phospholamban elude phosphorylation by protein kinase A J. Biol. Chem. 287 2012 26596 26605
23. S.J. Gruber, S. Haydon, and D.D. Thomas Phospholamban mutants compete with wild type for SERCA binding in living cells Biochem. Biophys. Res. Commun. 420 2012 236 240
24. C. Kang, and Q. Li Solution NMR study of integral membrane proteins Curr. Opin. Chem. Biol. 15 2011 560 569
25. H. Saito, and A. Naito NMR studies on fully hydrated membrane proteins, with emphasis on bacteriorhodopsin as a typical and prototype membrane protein Biochim. Biophys. Acta 1768 2007 3145 3161
26. M.F. Brown, M.P. Heyn, C. Job, S. Kim, S. Moltke, K. Nakanishi, A.A. Nevzorov, A.V. Struts, G.F.J. Salgado, and I. Wallat Solid-state H-2 NMR spectroscopy of retinal proteins in aligned membranes Biochim. Biophys. Acta 1768 2007 2979 3000
27. R. Mahalakshmi, and F.M. Marassi Orientation of the Escherichia coli outer membrane protein OmpX in phospholipid bilayer membranes determined by solid-state NMR Biochemistry 47 2008 6531 6538
28. R. Schneider, C. Ader, A. Lange, K. Giller, S. Hornig, O. Pongs, S. Becker, and M. Baldus Solid-state NMR spectroscopy applied to a chimeric potassium channel in lipid bilayers J. Am. Chem. Soc. 130 2008 7427 7435
29. G.A. Lorigan Magnetic resonance spectroscopic studies of the integral membrane protein phospholamban G.A. Webb, Modern Magnetic Resonance: Applications in Chemistry, Biological and Marine Sciences vol. 1 2008 Springer 313 318
30. G.W. Stockton, C.F. Polnaszek, A.P. Tulloch, F. Hasan, and I.C.P. Smith Molecular-motion and order in single-bilayer vesicles and multilamellar dispersions of egg lecithin and lecithin-cholesterol mixtures-deuterium nuclear magnetic-resonance study of specifically labeled lipids Biochemistry 15 1976 954 966
31. M. Traikia, D.B. Langlais, G.M. Cannarozzi, and P.F. Devaux High-resolution spectra of liposomes using MAS NMR. The case of intermediate-size vesicles J. Magn. Reson. 125 1997 140 144
32. A. Jesorka, and O. Orwar Liposomes: technologies and analytical applications Annu. Rev. Anal. Chem. 1 2008 801 832
33. P.C. Dave, E.K. Tiburu, K. Damodaran, and G.A. Lorigan Investigating structural changes in the lipid bilayer upon insertion of the transmembrane domain of the membrane-bound protein phospholamban utilizing P-31 and H-2 solid-state NMR spectroscopy Biophys. J. 86 2004 1564 1573
34. S.D. Chu, J.W. Hawes, and G.A. Lorigan Solid-state NMR spectroscopic studies on the interaction of sorbic acid with phospholipid membranes at different pH levels Magn. Reson. Chem. 47 2009 651 657
35. S. Abu-Baker, and G.A. Lorigan Phospholamban and its phosphorylated form interact differently with lipid bilayers: a (31)P, (2)H, and (13)C solid-state NMR spectroscopic study Biochemistry 45 2006 13312 13322
36. S. Abu-Baker, J.X. Lu, S.D. Chu, C.C. Brinn, C.A. Makaroff, and G.A. Lorigan Side chain and backbone dynamics of phospholamban in phospholipid bilayers utilizing H-2 and N-15 solid-state NMR spectroscopy Biochemistry 46 2007 11695 11706
37. D. Huster, K. Arnold, and K. Gawrisch Influence of docosahexaenoic acid and cholesterol on lateral lipid organization in phospholipid mixtures Biochemistry 37 1998 17299 17308
38. D. Huster, Y.L. Yao, K. Jakes, and M. Hong Conformational changes of colicin Ia channel-forming domain upon membrane binding: a solid-state NMR study Biochim. Biophys. Acta 1561 2002 159 170
39. M. Lafleur, B. Fine, E. Sternin, P.R. Cullis, and M. Bloom Smoothed orientational order profile lipid bilayers by H-2 nuclear magnetic resonance Biophys. J. 56 1989 1037 1041
40. A.C. Rigby, K.R. Barber, G.S. Shaw, and C.W.M. Grant Transmembrane region of the epidermal growth factor receptor: behavior and interactions via H-2 NMR Biochemistry 35 1996 12591 12601
41. A. Seelig, and J. Seelig Dynamic structure of fatty acyl chains in a phospholipid bilayer measured by deuterium magnetic-resonance Biochemistry 13 1974 4839 4845
42. X. Yu, S. Chu, A.E. Hagerman, and G.A. Lorigan Probing the interaction of polyphenols with lipid bilayers by solid-state NMR spectroscopy J. Agric. Food Chem. 59 2011 6783 6789
43. F. Aussenac, M. Laguerre, J.M. Schmitter, and E.J. Dufourc Detailed structure and dynamics of bicelle phospholipids using selectively deuterated and perdeuterated labels. H-2 NMR and molecular mechanics study Langmuir 19 2003 10468 10479
44. D. Massiot, F. Fayon, M. Capron, I. King, S. Le Calve, B. Alonso, J.O. Durand, B. Bujoli, Z.H. Gan, and G. Hoatson Modelling one- and two-dimensional solid-state NMR spectra Magn. Reson. Chem. 40 2002 70 76
45. M.A. McCabe, and S.R. Wassall Fast-fourier-transform depaking J. Magn. Reson. B 106 1995 80 82
46. M.A. McCabe, and S.R. Wassall Rapid deconvolution of NMR powder spectra by weighted fast Fourier transformation Solid State Nucl. Magn. Reson. 10 1997 53 61
47. P.C. Dave, E.K. Tiburu, N.A. Nusair, and G.A. Lorigan Calculating order parameter profiles utilizing magnetically aligned phospholipid bilayers for H-2 solid-state NMR studies Solid State Nucl. Magn. Reson. 24 2003 137 149
48. E.J. Dufourc, E.J. Parish, S. Chitrakorn, and I.C.P. Smith Structural and dynamical details of cholesterol lipid interaction as revealed by deuterium NMR Biochemistry 23 1984 6062 6071
49. J.-x. Lu, J. Blazyk, and G.A. Lorigan Exploring membrane selectivity of the antimicrobial peptide KIGAKI using solid-state NMR spectroscopy Biochim. Biophys. Acta 1758 2006 1303 1313
50. M. Gustavsson, N.J. Traaseth, C.B. Karim, E.L. Lockamy, D.D. Thomas, and G. Veglia Lipid-mediated folding/unfolding of phospholamban as a regulatory mechanism for the sarcoplasmic reticulum Ca(2 +)-ATPase J. Mol. Biol. 408 2011 755 765
51. M. Gustavsson, N.J. Traaseth, and G. Veglia Activating and deactivating roles of lipid bilayers on the Ca(2 +)-ATPase/phospholamban complex Biochemistry 50 2011 10367 10374
52. R.L. Cornea, L.R. Jones, J.M. Autry, and D.D. Thomas Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers Biochemistry 36 1997 2960 2967
53. E.L. Lockamy, R.L. Cornea, C.B. Karim, and D.D. Thomas Functional and physical competition between phospholamban and its mutants provides insight into the molecular mechanism of gene therapy for heart failure Biochem. Biophys. Res. Commun. 408 2011 388 392
54. S. Chu, A.T. Coey, and G.A. Lorigan Solid-state (2)H and (15)N NMR studies of side-chain and backbone dynamics of phospholamban in lipid bilayers: investigation of the N27A mutation Biochim. Biophys. Acta 1798 2010 210 215
55. B.L. Akin, Z. Chen, and L.R. Jones Superinhibitory phospholamban mutants compete with Ca(2 +) for binding to SERCA2a by stabilizing a unique nucleotide-dependent conformational state J. Biol. Chem. 285 2010 28540 28552
56. J. Zamoon, F. Nitu, C. Karim, D.D. Thomas, and G. Veglia Mapping the interaction surface of a membrane protein: unveiling the conformational switch of phospholamban in calcium pump regulation Proc. Natl. Acad. Sci. U. S. A. 102 2005 4747 4752
57. T.J.T. Pinheiro, and A. Watts Resolution of individual lipids in mixed phospholipid-membranes and specific lipid cytochrome-c interactions by magic-angle spinning solid-state P-31 NMR Biochemistry 33 1994 2459 2467
58. T.J.T. Pinheiro, and A. Watts Lipid specificity in the interaction of cytochrome-c with anionic phospholipid-bilayers revealed by solid-state P-31 NMR Biochemistry 33 1994 2451 2458
59. M. Gustavsson, N.J. Traaseth, and G. Veglia Probing ground and excited states of phospholamban in model and native lipid membranes by magic angle spinning NMR spectroscopy Biochim. Biophys. Acta Biomembr. 1818 2012 146 153
60. D.K. Ceholski, C.A. Trieber, and H.S. Young Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy J. Biol. Chem. 287 2012 16521 16529
61. X. Yu, and G.A. Lorigan Secondary Structure, Backbone Dynamics and Structural Topology of Phospholamban and Its Phosphorylated and Arg9Cys Mutated Forms in Phospholipid Bilayers Utilizing (13)C and (15)N Solid-state NMR Spectroscopy 2013 (in preparation)